Mortimer J. Buckley serves as the Chairman and Chief Executive Officer at Pfizer Inc. in 2024. As the leader of one of the world's largest pharmaceutical companies, Buckley is responsible for guiding Pfizer's strategic direction, overseeing its global operations, and ensuring the company's continued growth and innovation in the healthcare industry. Under his leadership, Pfizer has maintained its commitment to developing and delivering life-saving medicines and vaccines to patients worldwide.

Prior to his role at Pfizer, Buckley had an extensive career in the financial and healthcare sectors. He joined Pfizer in 2019 as the Chief Financial Officer, where he played a crucial role in strengthening the company's financial position and driving its long-term growth strategy. Before joining Pfizer, Buckley held various leadership positions at major financial institutions, including serving as the Chief Operating Officer at a leading global investment firm. His expertise in finance, operations, and strategic planning has been instrumental in shaping Pfizer's success.

As a non-independent board member at Pfizer, Buckley is not part of the Audit, Governance, Audit Committee, or Governance Committee. However, his role as CEO involves working closely with these committees to ensure the company's compliance with regulatory requirements and best practices in corporate governance. Buckley's professional background and leadership skills make him well-suited to guide Pfizer through the complex challenges and opportunities in the pharmaceutical industry, as the company continues to develop innovative treatments and improve patient outcomes worldwide.